Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 1, Pages 225
Publisher
MDPI AG
Online
2020-12-29
DOI
10.3390/ijms22010225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of progression in systemic sclerosis patients with interstitial lung disease
- (2020) Oliver Distler et al. EUROPEAN RESPIRATORY JOURNAL
- Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases
- (2020) Minjie Wan et al. Frontiers in Immunology
- Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
- (2020) Caterina Vacchi et al. Journal of Clinical Medicine
- Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome
- (2020) Dominique Clement et al. Journal of Oncology
- Vascular Permeability in the Fibrotic Lung
- (2020) Clemens K. Probst et al. EUROPEAN RESPIRATORY JOURNAL
- Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis
- (2020) Elana J. Bernstein et al. Arthritis & Rheumatology
- Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
- (2020) Yet H. Khor et al. European Respiratory Review
- Serotonin receptor type 2B activation augments TNF‐α‐induced matrix mineralization in murine valvular interstitial cells
- (2020) Felicia Fong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Platelets in Systemic Sclerosis: the Missing Link Connecting Vasculopathy, Autoimmunity, and Fibrosis?
- (2019) Konstantinos Ntelis et al. Current Rheumatology Reports
- Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis
- (2019) Jonathan A. Kropski et al. Annual Review of Medicine
- Current and Future Idiopathic Pulmonary Fibrosis Therapy
- (2019) Fabiana Baldi et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rheumatoid arthritis disease activity predicting incident clinically‐apparent RA ‐associated interstitial lung disease: A prospective cohort study
- (2019) Jeffrey A. Sparks et al. Arthritis & Rheumatology
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Thoracic Manifestations of Rheumatoid Arthritis
- (2019) Anthony J. Esposito et al. CLINICS IN CHEST MEDICINE
- New trajectories in the treatment of interstitial lung disease
- (2019) Julie Morisset et al. CURRENT OPINION IN PULMONARY MEDICINE
- Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis
- (2019) Linda Elowsson Rendin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- The therapy of idiopathic pulmonary fibrosis: what is next?
- (2019) Vivien Somogyi et al. European Respiratory Review
- Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
- (2019) Anna-Maria Hoffmann-Vold et al. EBioMedicine
- Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes
- (2018) Anna Löfdahl et al. AMERICAN JOURNAL OF PATHOLOGY
- Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis
- (2018) Raphael Leblanc et al. BRITISH JOURNAL OF PHARMACOLOGY
- Tryptophan metabolites kynurenine and serotonin regulate fibroblast activation and fibrosis
- (2018) David M. Dolivo et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink
- (2018) Jeremy G. Royle et al. CLINICAL RHEUMATOLOGY
- Serotonin Exhibits Accelerated Bleomycin-Induced Pulmonary Fibrosis through TPH1 Knockout Mouse Experiments
- (2018) Jingyao Zhang et al. MEDIATORS OF INFLAMMATION
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- 5-HT2 and 5-HT2B antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-β1 induced non-canonical signaling pathways including STAT3
- (2018) Saurabh Chaturvedi et al. International Journal of Rheumatic Diseases
- Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
- (2018) Karina Raimundo et al. JOURNAL OF RHEUMATOLOGY
- 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride
- (2017) Mona K. Tawfik et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Systemic sclerosis
- (2017) Christopher P Denton et al. LANCET
- Detection of early endothelial damage in patients with Raynaud's phenomenon
- (2017) Roberta Gualtierotti et al. MICROVASCULAR RESEARCH
- The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
- (2017) Emma Lefrançais et al. NATURE
- Dermal white adipose tissue implicated in SSc pathogenesis
- (2017) John Varga et al. Nature Reviews Rheumatology
- Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2017) Nour C. Bacha et al. Stem Cell Reviews and Reports
- Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice
- (2017) Dalia M. El-Tanbouly et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
- (2017) Debomita Chakraborty et al. Nature Communications
- Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2017) Nour C. Bacha et al. Stem Cell Reviews and Reports
- The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
- (2017) Fernando J Martinez et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Serotonin Is Involved in Autoimmune Arthritis through Th17 Immunity and Bone Resorption
- (2016) Yasmine Chabbi-Achengli et al. AMERICAN JOURNAL OF PATHOLOGY
- A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030
- (2016) Niklas Palmqvist et al. Journal of Inflammation-London
- Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension
- (2016) Robert J. Aiello et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- The antifibrotic effects of alveolar macrophages 5-HT2C receptors blockade on bleomycin-induced pulmonary fibrosis in rats
- (2016) Samah M. Elaidy et al. Pharmacological Reports
- Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
- (2016) Elisabetta Balestro et al. PLoS One
- Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1
- (2016) Raphaël Lemaire et al. Arthritis & Rheumatology
- Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension
- (2016) James D. West et al. PLoS One
- Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation
- (2016) Richard W. D. Welford et al. Scientific Reports
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
- (2015) John Hutchinson et al. EUROPEAN RESPIRATORY JOURNAL
- Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs
- (2015) Amarnath S. Marudamuthu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of angiogenesis by platelets in systemic sclerosis patients
- (2015) Daniela Hirigoyen et al. ARTHRITIS RESEARCH & THERAPY
- Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma
- (2015) Kazuyuki Tsujino et al. Current Rheumatology Reports
- The role of serotonin and its receptors in activation of immune responses and inflammation
- (2014) M. S. Shajib et al. Acta Physiologica
- A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study
- (2014) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Response of Hemopoietic, Progenitor, and Multipotent Mesenchymal Stromal Cells to Administration of Ketanserin during Pulmonary Fibrosis
- (2014) A. M. Dygai et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis
- (2014) S. Barratt et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
- (2014) Ana Camelo et al. Frontiers in Pharmacology
- Inhibition of Platelet Activation by Clopidogrel Prevents Hypertension-Induced Cardiac Inflammation and Fibrosis
- (2013) Li-Xin Jia et al. CARDIOVASCULAR DRUGS AND THERAPY
- The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells
- (2013) Ana C. R. Moreno et al. FEBS Journal
- Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis
- (2012) David M. Smadja et al. ANGIOGENESIS
- Platelets can enhance vascular permeability
- (2012) N. Cloutier et al. BLOOD
- Impact of 5-HT3 receptor antagonists on peripheral and central diseases
- (2012) Gohar Fakhfouri et al. DRUG DISCOVERY TODAY
- Modulation of antigen-induced responses by serotonin and prostaglandin E2 via EP1 and EP4 receptors in the peripheral rat lung
- (2012) Anna-Karin Larsson-Callerfelt et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 5-HT2B antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation
- (2012) Joshua D. Hutcheson et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Platelets: active players in the pathogenesis of arthritis and SLE
- (2012) Eric Boilard et al. Nature Reviews Rheumatology
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca2+ signaling
- (2012) Yan-Ping Zhang et al. THROMBOSIS RESEARCH
- Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system
- (2011) Yashodhar P. Bhandary et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic Pulmonary Fibrosis May Be a Disease of Recurrent, Tractional Injury to the Periphery of the Aging Lung: A Unifying Hypothesis Regarding Etiology and Pathogenesis
- (2011) Kevin O. Leslie ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- PAI-1 in tissue fibrosis
- (2011) Asish K. Ghosh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Platelet-derived serotonin links vascular disease and tissue fibrosis
- (2011) Clara Dees et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
- (2011) Mohammad R Ebrahimkhani et al. NATURE MEDICINE
- Serotonin receptors and heart valve disease—It was meant 2B
- (2011) Joshua D. Hutcheson et al. PHARMACOLOGY & THERAPEUTICS
- Animal models of systemic sclerosis: Prospects and limitations
- (2010) Christian Beyer et al. ARTHRITIS AND RHEUMATISM
- Corticosteroids and the risk of scleroderma renal crisis: a systematic review
- (2010) Gerald Trang et al. RHEUMATOLOGY INTERNATIONAL
- Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
- (2010) M. Konigshoff et al. THORAX
- Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake
- (2009) I. Lopez-Vilchez et al. CARDIOVASCULAR RESEARCH
- Serotonergic drugs and valvular heart disease
- (2009) Richard B Rothman et al. Expert Opinion On Drug Safety
- The phenotype of murine wound macrophages
- (2009) Jean M. Daley et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Transforming growth factor β as a therapeutic target in systemic sclerosis
- (2009) John Varga et al. Nature Reviews Rheumatology
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice
- (2009) Zhiqian Yu et al. THROMBOSIS AND HAEMOSTASIS
- Pulmonary hypertension in interstitial lung disease
- (2008) J. Behr et al. EUROPEAN RESPIRATORY JOURNAL
- Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
- (2008) A. Fabre et al. EUROPEAN RESPIRATORY JOURNAL
- Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor- -Induced Inflammation with Extraordinary Potency
- (2008) B. Yu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells
- (2008) Matthias F. Seidel et al. RHEUMATOLOGY INTERNATIONAL
- Function, expression, and characterization of the serotonin transporter in the native human intestine
- (2007) Ravinder K. Gill et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis
- (2007) A Kling et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More